Foresite Capital Fund VI LP - 30 Sep 2025 SCHEDULE 13G/A Report for CASI Pharmaceuticals, Inc. Ordinary Shares, par value $0.0001 (CASI)

Filing Manager
Foresite Capital Fund VI LP
Reporting Manager
Foresite Capital Fund VI LP
Security
CASI Pharmaceuticals, Inc. Ordinary Shares, par value $0.0001
Symbol
CASI
Shares outstanding
15,554,857 shares
Disclosed Ownership
979,956 shares
Ownership
6.3%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 16:05:46 UTC
Date of event
30 Sep 2025
Previous filing
12 Aug 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Foresite Capital Fund VI LP 6.3% 979,956 979,956 0 /s/ James Tananbaum James Tananbaum, Managing Member of the General Partner
Foresite Capital Management VI LLC 6.3% 979,956 979,956 0 /s/ James Tananbaum James Tananbaum, Managing Member
James Tananbaum 6.3% 979,956 979,956 0 /s/ James Tananbaum James Tananbaum